Aβ25–35 Suppresses Mitochondrial Biogenesis in Primary Hippocampal Neurons

[1]  K. Kuča,et al.  A Direct Interaction Between Mitochondrial Proteins and Amyloid-β Peptide and its Significance for the Progression and Treatment of Alzheimer’s Disease , 2015, Current medicinal chemistry.

[2]  G. Casadesus,et al.  Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease. , 2014, Biochimica et biophysica acta.

[3]  A. Martínez-Amat,et al.  The combination of oral quercetin supplementation and exercise prevents brain mitochondrial biogenesis , 2014, Genes & Nutrition.

[4]  Xinglong Wang,et al.  Oxidative stress and mitochondrial dysfunction in Alzheimer's disease. , 2014, Biochimica et biophysica acta.

[5]  N. Jia,et al.  Taurine attenuates amyloid β 1-42-induced mitochondrial dysfunction by activating of SIRT1 in SK-N-SH cells. , 2014, Biochemical and biophysical research communications.

[6]  Yanzhuang Wang,et al.  Aβ-induced Golgi fragmentation in Alzheimer’s disease enhances Aβ production , 2014, Proceedings of the National Academy of Sciences.

[7]  F. Khodagholi,et al.  Monitoring of Neuronal Loss in the Hippocampus of Aβ-Injected Rat: Autophagy, Mitophagy, and Mitochondrial Biogenesis Stand Against Apoptosis , 2014, NeuroMolecular Medicine.

[8]  Brian J. Bacskai,et al.  Mitochondrial Alterations near Amyloid Plaques in an Alzheimer's Disease Mouse Model , 2013, The Journal of Neuroscience.

[9]  J. Prehn,et al.  Bmf upregulation through the AMP-activated protein kinase pathway may protect the brain from seizure-induced cell death , 2013, Cell Death and Disease.

[10]  Young Woo Kim,et al.  Red ginseng abrogates oxidative stress via mitochondria protection mediated by LKB1-AMPK pathway , 2013, BMC Complementary and Alternative Medicine.

[11]  D. Brautigan,et al.  α–SNAP inhibits AMPK signaling to reduce mitochondrial biogenesis and dephosphorylates Thr172 in AMPKα in vitro , 2013, Nature Communications.

[12]  K. Lim,et al.  AMP Kinase Activation Mitigates Dopaminergic Dysfunction and Mitochondrial Abnormalities in Drosophila Models of Parkinson's Disease , 2012, The Journal of Neuroscience.

[13]  R. de Cabo,et al.  SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. , 2012, Cell metabolism.

[14]  I. Mook‐Jung,et al.  Mitochondria-Specific Accumulation of Amyloid β Induces Mitochondrial Dysfunction Leading to Apoptotic Cell Death , 2012, PloS one.

[15]  Hyoung-Gon Lee,et al.  Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer’s disease , 2012, Journal of neurochemistry.

[16]  G. Brooks,et al.  Mild heat stress induces mitochondrial biogenesis in C2C12 myotubes. , 2012, Journal of applied physiology.

[17]  P. Reddy,et al.  Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease. , 2011, Human molecular genetics.

[18]  R. Scarpulla,et al.  Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. , 2011, Biochimica et biophysica acta.

[19]  Z. Quezado,et al.  Disruption of adaptive energy metabolism and elevated ribosomal p-S6K1 levels contribute to INCL pathogenesis: partial rescue by resveratrol. , 2011, Human molecular genetics.

[20]  Jürgen Götz,et al.  Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease , 2011, Nature Reviews Neuroscience.

[21]  Ezzie Hutchinson,et al.  Systems neuroscience: The stress of dieting , 2011, Nature Reviews Neuroscience.

[22]  S. Rohrbach,et al.  Mitochondrial Biogenesis and Peroxisome Proliferator–Activated Receptor-γ Coactivator-1α (PGC-1α) Deacetylation by Physical Activity , 2010, Diabetes.

[23]  S. Rohrbach,et al.  Mitochondrial Biogenesis and Peroxisome Proliferator–Activated Receptor-γ Coactivator-1α (PGC-1α) Deacetylation by Physical Activity , 2010, Diabetes.

[24]  P. Griffin,et al.  Faculty Opinions recommendation of Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1alpha pathway. , 2010 .

[25]  Qing Yang,et al.  Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK–SIRT1–PGC-1α pathway , 2010, Proceedings of the National Academy of Sciences.

[26]  N. Ruderman,et al.  AMPK and SIRT1: a long-standing partnership? , 2010, American journal of physiology. Endocrinology and metabolism.

[27]  W. Fan,et al.  Differential effects of melatonin on amyloid‐β peptide 25–35‐induced mitochondrial dysfunction in hippocampal neurons at different stages of culture , 2010, Journal of pineal research.

[28]  E. Kosenko,et al.  Subcellular and metabolic examination of amyloid-β peptides in Alzheimer disease pathogenesis: Evidence for Aβ25–35 , 2010, Experimental Neurology.

[29]  I. Cho,et al.  Resveratrol Protects Mitochondria against Oxidative Stress through AMP-Activated Protein Kinase-Mediated Glycogen Synthase Kinase-3β Inhibition Downstream of Poly(ADP-ribose)polymerase-LKB1 Pathway , 2009, Molecular Pharmacology.

[30]  P. Puigserver,et al.  AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity , 2009, Nature.

[31]  P. Filipcik,et al.  Cortical and Hippocampal Neurons from Truncated Tau Transgenic Rat Express Multiple Markers of Neurodegeneration , 2009, Cellular and Molecular Neurobiology.

[32]  J. Buxbaum,et al.  PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia. , 2009, Archives of neurology.

[33]  M. Masserini,et al.  TrkA pathway activation induced by amyloid-beta (Abeta) , 2009, Molecular and Cellular Neuroscience.

[34]  D. Bennett,et al.  Sirtuin 1 Reduction Parallels the Accumulation of Tau in Alzheimer Disease , 2009, Journal of neuropathology and experimental neurology.

[35]  V. Sartorelli,et al.  Comparing and contrasting the roles of AMPK and SIRT1 in metabolic tissues , 2008, Cell cycle.

[36]  M. Ott,et al.  The ups and downs of SIRT1. , 2008, Trends in biochemical sciences.

[37]  G. McKhann,et al.  Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease , 2008, Nature Medicine.

[38]  F. Mouliere,et al.  Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats , 2008, Neurobiology of Disease.

[39]  E. Hoffman,et al.  Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. , 2008, Developmental cell.

[40]  D. Hardie,et al.  AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy , 2007, Nature Reviews Molecular Cell Biology.

[41]  B. Spiegelman,et al.  AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α , 2007, Proceedings of the National Academy of Sciences.

[42]  Andre Fischer,et al.  SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis , 2007, The EMBO journal.

[43]  B. Spiegelman,et al.  A fundamental system of cellular energy homeostasis regulated by PGC-1α , 2007, Proceedings of the National Academy of Sciences.

[44]  P. Agostinho,et al.  Susceptibility of hippocampal neurons to Aβ peptide toxicity is associated with perturbation of Ca2+ homeostasis , 2007, Brain Research.

[45]  P. Puigserver,et al.  Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC‐1α , 2007, The EMBO journal.

[46]  J. Busciglio,et al.  Different Conformations of Amyloid β Induce Neurotoxicity by Distinct Mechanisms in Human Cortical Neurons , 2006, The Journal of Neuroscience.

[47]  Christoph Handschin,et al.  Metabolic control through the PGC-1 family of transcription coactivators. , 2005, Cell metabolism.

[48]  S. Nemoto,et al.  SIRT1 Functionally Interacts with the Metabolic Regulator and Transcriptional Coactivator PGC-1α* , 2005, Journal of Biological Chemistry.

[49]  D. Selkoe,et al.  Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseases , 2004, Nature Cell Biology.

[50]  M. Meselhy,et al.  Aβ(25–35)-Induced Memory Impairment, Axonal Atrophy, and Synaptic Loss are Ameliorated by M1, A Metabolite of Protopanaxadiol-Type Saponins , 2004, Neuropsychopharmacology.

[51]  Douglas L. Rothman,et al.  Mitochondrial Dysfunction in the Elderly: Possible Role in Insulin Resistance , 2003, Science.

[52]  M. Duchen,et al.  β-Amyloid Fragment 25–35 Causes Mitochondrial Dysfunction in Primary Cortical Neurons , 2002, Neurobiology of Disease.

[53]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[54]  Rick B. Vega,et al.  The Coactivator PGC-1 Cooperates with Peroxisome Proliferator-Activated Receptor α in Transcriptional Control of Nuclear Genes Encoding Mitochondrial Fatty Acid Oxidation Enzymes , 2000, Molecular and Cellular Biology.

[55]  T. Bates,et al.  β‐Amyloid fragment 25–35 selectively decreases complex IV activity in isolated mitochondria , 1999, FEBS letters.

[56]  V. Mootha,et al.  Mechanisms Controlling Mitochondrial Biogenesis and Respiration through the Thermogenic Coactivator PGC-1 , 1999, Cell.

[57]  R. Scarpulla,et al.  Activation of the human mitochondrial transcription factor A gene by nuclear respiratory factors: a potential regulatory link between nuclear and mitochondrial gene expression in organelle biogenesis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[58]  Carl W. Cotman,et al.  Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[59]  D. Kirschner,et al.  Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. , 1990, Science.

[60]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[61]  J. Bennett,et al.  Mitochondrial DNA copy numbers in pyramidal neurons are decreased and mitochondrial biogenesis transcriptome signaling is disrupted in Alzheimer's disease hippocampi. , 2014, Journal of Alzheimer's disease : JAD.

[62]  S. Yan,et al.  Amyloid-beta-induced mitochondrial dysfunction. , 2007, Journal of Alzheimer's disease : JAD.

[63]  B. Spiegelman,et al.  AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. , 2007, Proceedings of the National Academy of Sciences of the United States of America.

[64]  S. Yan,et al.  Amyloid-β-Induced Mitochondrial Dysfunction , 2007 .

[65]  Steven P Gygi,et al.  Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. , 2005, Nature.

[66]  M. Duchen,et al.  Beta-amyloid fragment 25-35 causes mitochondrial dysfunction in primary cortical neurons. , 2002, Neurobiology of disease.